RRM2 and acute myeloid leukemia: Aimiuwu et al. demonstrated that 5-Azacytidine (5-azaC) could cause perturbation of deoxyribonucleotide pools (LAML) and that RRM2 may be a novel molecular target of 5-azaC in AML [31].